Sales decline 3.97% to Rs 630.63 crore
Net profit of Glaxosmithkline Pharma declined 15.62% to Rs 116.88 crore in the quarter ended December 2013 as against Rs 138.51 crore during the previous quarter ended December 2012. Sales declined 3.97% to Rs 630.63 crore in the quarter ended December 2013 as against Rs 656.69 crore during the previous quarter ended December 2012.For the full year,net profit declined 13.06% to Rs 501.88 crore in the year ended December 2013 as against Rs 577.26 crore during the previous year ended December 2012. Sales declined 3.07% to Rs 2520.17 crore in the year ended December 2013 as against Rs 2599.93 crore during the previous year ended December 2012.
ParticularsQuarter EndedYear EndedDec. 2013Dec. 2012% Var.Dec. 2013Dec. 2012% Var.Sales630.63656.69 -4 2520.172599.93 -3 OPM %18.7529.98 -20.7231.36 - PBDT166.03239.00 -31 723.051012.62 -29 PBT160.26234.42 -32 703.17994.78 -29 NP116.88138.51 -16 501.88577.26 -13
Powered by Capital Market - Live News
